Ironwood Pharmaceuticals (IRWD) Other Working Capital Changes (2010 - 2026)

Ironwood Pharmaceuticals has reported Other Working Capital Changes for 9 years, with the latest figure at -$621000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 8.57% year-over-year to -$621000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 8.76% YoY) and the FY2025 annual result came in at -$2.4 million, down 8.96% from the prior year.
• Other Working Capital Changes eased to -$621000.0 in Q1 2026 per IRWD's latest filing, from -$612000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.6 million in Q1 2024 and troughed at -$6.1 million in Q4 2023.
• A 5-year average of -$295882.4 and a median of -$75000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes retreated 9.77% in 2022, then gained 0.83% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$473000.0 in 2022, then dropped by 9.09% to -$516000.0 in 2023, then declined by 8.91% to -$562000.0 in 2024, then dropped by 8.9% to -$612000.0 in 2025, then retreated by 1.47% to -$621000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$621000.0, -$612000.0, and -$603000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.